Published in Stem Cells on October 01, 2010
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol (2012) 2.50
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23
Reprogramming cellular identity for regenerative medicine. Cell (2012) 1.71
Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol (2010) 1.65
RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One (2011) 1.60
A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. J Cell Sci (2011) 1.50
Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci (2011) 1.40
Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech (2013) 1.37
Cell therapeutics in Parkinson's disease. Neurotherapeutics (2011) 1.32
Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc Lond B Biol Sci (2011) 1.17
Clinical application of stem cell therapy in Parkinson's disease. BMC Med (2012) 1.07
From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. Stem Cells Transl Med (2011) 1.07
Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med (2012) 1.05
New lessons learned from disease modeling with induced pluripotent stem cells. Curr Opin Genet Dev (2012) 1.04
Inducing iPSCs to escape the dish. Cell Stem Cell (2011) 1.03
The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. J Biol Chem (2013) 1.00
Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev (2011) 0.99
Standardized generation and differentiation of neural precursor cells from human pluripotent stem cells. Stem Cell Rev (2013) 0.96
Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int (2012) 0.95
Induced pluripotent stem cells in the study of neurological diseases. Stem Cell Res Ther (2011) 0.93
Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells. Stem Cells Dev (2013) 0.91
Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells. J Neurogenet (2014) 0.91
New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism. Cell Metab (2013) 0.90
Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. PLoS One (2011) 0.90
Concise review: Human cell engineering: cellular reprogramming and genome editing. Stem Cells (2012) 0.90
Cell therapy for multiple sclerosis. Neurotherapeutics (2011) 0.89
Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr Cardiol Rev (2013) 0.88
The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases. Stem Cell Res Ther (2011) 0.88
Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int (2011) 0.88
Primary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide. Mol Biol Cell (2014) 0.87
Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease. PLoS One (2013) 0.86
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? J Comp Neurol (2014) 0.86
Concise review: drug discovery in the age of the induced pluripotent stem cell. Stem Cells Transl Med (2014) 0.86
Comparison and optimization of hiPSC forebrain cortical differentiation protocols. PLoS One (2014) 0.86
ECM-dependent HIF induction directs trophoblast stem cell fate via LIMK1-mediated cytoskeletal rearrangement. PLoS One (2013) 0.85
Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med (2013) 0.84
Intracerebral transplantation for neurological disorders. Lessons from developmental, experimental, and clinical studies. Front Cell Neurosci (2012) 0.84
Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? J Biomed Biotechnol (2012) 0.83
Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics (2013) 0.83
Converted neural cells: induced to a cure? Protein Cell (2012) 0.83
Patient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate models. Stem Cells Cloning (2013) 0.83
Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Transl Med (2014) 0.82
Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice. PLoS One (2013) 0.82
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology (2012) 0.82
Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. Stem Cell Reports (2014) 0.81
cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications. Stem Cell Reports (2015) 0.81
Generation of Reactive Oxygen Species (ROS) and Pro-Inflammatory Signaling in Human Brain Cells in Primary Culture. J Alzheimers Dis Parkinsonism (2012) 0.80
The potential of iPS cells in synucleinopathy research. Stem Cells Int (2012) 0.80
Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice. Stem Cell Res Ther (2013) 0.80
Progress on stem cell research towards the treatment of Parkinson's disease. Stem Cell Res Ther (2012) 0.80
Pluripotent stem cells for Parkinson's disease: progress and challenges. Stem Cell Res Ther (2013) 0.80
High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform. Sci Rep (2016) 0.80
The State of Play with iPSCs and Spinal Cord Injury Models. J Clin Med (2015) 0.79
Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res (2015) 0.78
Treatment of Parkinson's disease using cell transplantation. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow. PLoS One (2012) 0.78
Induced pluripotency for translational research. Genomics Proteomics Bioinformatics (2013) 0.78
Modeling psychiatric disorders with patient-derived iPSCs. Curr Opin Neurobiol (2015) 0.77
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death Dis (2015) 0.77
Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells. Stem Cell Res Ther (2014) 0.77
Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. Front Physiol (2012) 0.76
Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform. Sci Rep (2017) 0.76
Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine. Front Surg (2014) 0.75
Stem cells as in vitro model of Parkinson's disease. Stem Cells Int (2012) 0.75
Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything? Stem Cells Int (2012) 0.75
Efficient derivation of dopaminergic neurons from SOX1(-) floor plate cells under defined culture conditions. J Biomed Sci (2016) 0.75
Glial progenitor cell-based treatment of the childhood leukodystrophies. Exp Neurol (2016) 0.75
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci (2016) 0.75
The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors. Int J Nanomedicine (2016) 0.75
Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research. Psychiatry Investig (2015) 0.75
A constraint-based modelling approach to metabolic dysfunction in Parkinson's disease. Comput Struct Biotechnol J (2015) 0.75
Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research? Schizophr Bull (2013) 0.75
Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies. Curr Neurol Neurosci Rep (2015) 0.75
Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna) (2012) 0.75
Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages. Transl Psychiatry (2017) 0.75
Isolation of Human Neural Stem Cells from the Amniotic Fluid with Diagnosed Neural Tube Defects. Stem Cells Dev (2015) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
TM4 microarray software suite. Methods Enzymol (2006) 13.78
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009) 8.97
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Naive and primed pluripotent states. Cell Stem Cell (2009) 7.15
A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell (2008) 5.90
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood (2009) 4.22
LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci (2006) 3.58
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (2010) 3.53
Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (2005) 3.38
Dopaminergic differentiation of human embryonic stem cells. Stem Cells (2004) 2.30
Lrrk2 and Lewy body disease. Ann Neurol (2006) 2.00
Transfection techniques for neuronal cells. J Neurosci (2010) 1.58
Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol (2006) 1.58
Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One (2009) 1.38
Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells (2003) 1.30
Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci (2007) 1.21
An improved method for generating and identifying human induced pluripotent stem cells. Methods Mol Biol (2010) 1.07
Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J Biol Chem (2002) 0.88
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009) 8.97
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res (2013) 7.77
The human serum metabolome. PLoS One (2011) 5.55
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell (2007) 4.81
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods (2013) 4.61
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood (2009) 4.22
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Highly multiplexed subcellular RNA sequencing in situ. Science (2014) 3.77
Gene expression in human embryonic stem cell lines: unique molecular signature. Blood (2003) 3.73
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res (2011) 3.58
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (2010) 3.53
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood (2011) 3.43
Differences between human and mouse embryonic stem cells. Dev Biol (2004) 3.30
Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood (2011) 3.21
Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells (2008) 3.14
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood (2007) 3.05
Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells (2005) 2.81
Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells (2005) 2.74
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens (2010) 2.68
Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci (2008) 2.67
Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol (2004) 2.60
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med (2005) 2.46
Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem (2002) 2.45
Dopaminergic differentiation of human embryonic stem cells. Stem Cells (2004) 2.30
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. Stem Cells Dev (2014) 2.27
Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res (2012) 2.09
Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology (2010) 2.08
Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn (2004) 2.01
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood (2013) 2.00
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A (2008) 1.99
Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther (2003) 1.87
Properties of a fetal multipotent neural stem cell (NEP cell). Dev Biol (2002) 1.75
Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev (2004) 1.75
Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem (2004) 1.73
Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res (2011) 1.70
Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci U S A (2007) 1.70
HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells (2006) 1.66
CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol (2004) 1.66
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood (2009) 1.66
Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem (2006) 1.65
Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One (2008) 1.64
Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura. Eur J Haematol (2003) 1.64
Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells (2007) 1.62
Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Res (2007) 1.61
Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol (2005) 1.61
Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn (2004) 1.60
Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell (2008) 1.60
A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells (2009) 1.59
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol (2006) 1.58
beta1 integrin maintains integrity of the embryonic neocortical stem cell niche. PLoS Biol (2009) 1.57
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Prostate (2006) 1.55
Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol (2003) 1.53
Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J Comp Neurol (2007) 1.51
A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. J Cell Sci (2011) 1.50
Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells. BMC Dev Biol (2008) 1.49
Developing safe therapies from human pluripotent stem cells. Nat Biotechnol (2009) 1.48
Toward cell replacement therapy: promises and caveats. Exp Neurol (2003) 1.47
De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(-) cells in patients with idiopathic thrombocytopenic purpura. Blood (2008) 1.44
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res (2008) 1.43
Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells (2008) 1.43
Neuroglobin expression in neurogenesis. Neurosci Lett (2013) 1.42
Sox2 expression defines a heterogeneous population of neurosphere-forming cells in the adult murine brain. Aging Cell (2005) 1.42
Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet (2004) 1.42
Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol (2005) 1.41
Evidence for involvement of calcitonin gene-related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism. J Am Coll Cardiol (2008) 1.40
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet (2012) 1.40
Recent advances in the study on capsaicinoids and capsinoids. Eur J Pharmacol (2010) 1.40
Colocalization, physical, and functional interaction between Werner and Bloom syndrome proteins. J Biol Chem (2002) 1.39
Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One (2009) 1.38
Brg1 is required for murine neural stem cell maintenance and gliogenesis. Dev Biol (2005) 1.38
Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells (2004) 1.36
Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells (2007) 1.35
Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol (2003) 1.35
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood (2011) 1.34
Facile preparation of low cytotoxicity fluorescent carbon nanocrystals by electrooxidation of graphite. Chem Commun (Camb) (2008) 1.33
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood (2002) 1.33
Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Mol Cell Biol (2008) 1.32
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc (2012) 1.32
Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins. Cell Stem Cell (2008) 1.32